• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后放疗时机与涎腺癌切除术患者生存的关系:单中心长期随访结果

Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.

机构信息

University of Washington, Department of Medicine, Division of Medical Oncology, United States.

Fred Hutchinson Cancer Research Institute, Division of Clinical Biostatistics, United States.

出版信息

Oral Oncol. 2021 Dec;123:105626. doi: 10.1016/j.oraloncology.2021.105626. Epub 2021 Nov 19.

DOI:10.1016/j.oraloncology.2021.105626
PMID:34801976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8671342/
Abstract

OBJECTIVES

Timely administration of postoperative radiation therapy (PORT) impacts oncologic outcomes in resected squamous cell carcinomas of the head and neck. Salivary gland cancers (SGCs) are uncommon, and timing of PORT has not been extensively explored. We aimed to determine if the interval between surgery and PORT impacts outcomes in SGCs.

MATERIALS AND METHODS

This is a retrospective study of patients with SGCs who underwent curative intent surgical resection followed by adjuvant PORT. Locoregional recurrence free survival (LRFS), disease free survival (DFS), and overall survival (OS) were estimated using the Kaplan Meier method. A multivariate analysis explored the association between demographics, tumor characteristics, and PORT timing with oncologic outcomes using a stepwise Cox proportional hazards model.

RESULTS

180 eligible patients were identified. The median time to PORT start was 61 (range 8-121) days. 169 (93.5%) of patients received neutron radiation. With a median follow up of 8.2 years in surviving patients, the 10-year OS and LRFS estimates were 61% and 53%. In a multivariate analysis, nodal involvement, histologic grade, and age at diagnosis were associated with OS, while nodal involvement, tumor size, and age at diagnosis were associated with LRFS and DFS. Time to PORT start or completion was not statistically associated with survival outcomes.

CONCLUSION

SGC patients who underwent surgery in our tertiary institution received PORT within a median of 61 days after surgery. With long term follow up, PORT timing in this retrospective series was not associated with worse oncologic outcomes, and support timely administration of PORT.

摘要

目的

术后放疗(PORT)的及时给予会影响头颈部鳞状细胞癌切除术后的肿瘤学结果。唾液腺癌(SGCs)并不常见,PORT 的时机尚未广泛探讨。我们旨在确定手术和 PORT 之间的时间间隔是否会影响 SGC 的结果。

材料和方法

这是一项对接受根治性手术切除后接受辅助 PORT 的 SGC 患者的回顾性研究。使用 Kaplan-Meier 方法估计局部区域无复发生存率(LRFS)、无病生存率(DFS)和总生存率(OS)。使用逐步 Cox 比例风险模型的多变量分析探讨了人口统计学、肿瘤特征和 PORT 时间与肿瘤学结果之间的关联。

结果

确定了 180 名合格患者。PORT 开始的中位时间为 61 天(范围 8-121 天)。169 例(93.5%)患者接受了中子放疗。在存活患者的中位随访 8.2 年后,10 年 OS 和 LRFS 估计值分别为 61%和 53%。在多变量分析中,淋巴结受累、组织学分级和诊断时的年龄与 OS 相关,而淋巴结受累、肿瘤大小和诊断时的年龄与 LRFS 和 DFS 相关。PORT 开始或完成的时间与生存结果无统计学关联。

结论

在我们的三级机构接受手术的 SGC 患者在手术后中位数 61 天内接受 PORT。在长期随访中,本回顾性系列中 PORT 时间与肿瘤学结果没有相关性,支持及时给予 PORT。

相似文献

1
Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.术后放疗时机与涎腺癌切除术患者生存的关系:单中心长期随访结果
Oral Oncol. 2021 Dec;123:105626. doi: 10.1016/j.oraloncology.2021.105626. Epub 2021 Nov 19.
2
Evaluation of Surgical Margin Status in Patients With Salivary Gland Cancer.评估涎腺癌患者的手术切缘状态。
JAMA Otolaryngol Head Neck Surg. 2022 Feb 1;148(2):128-138. doi: 10.1001/jamaoto.2021.3459.
3
The protective role of postoperative radiation therapy in low and intermediate grade major salivary gland malignancies: A study of the Canadian Head and Neck Collaborative Research Initiative.术后放疗在低级别和中级别大型涎腺癌中的保护作用:加拿大头颈部合作研究倡议研究。
Cancer. 2023 Oct 15;129(20):3263-3274. doi: 10.1002/cncr.34932. Epub 2023 Jul 4.
4
Outcome of surgery and post-operative radiotherapy for major salivary gland carcinoma: ten year experience from a single institute.大唾液腺癌的手术及术后放疗结果:来自单一机构的十年经验
Asian Pac J Cancer Prev. 2014;15(19):8259-63. doi: 10.7314/apjcp.2014.15.19.8259.
5
Association of Adjuvant Chemoradiotherapy vs Radiotherapy Alone With Survival in Patients With Resected Major Salivary Gland Carcinoma: Data From the National Cancer Data Base.辅助放化疗与单纯放疗对手术切除的大唾液腺癌患者生存率的影响:来自国家癌症数据库的数据
JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1100-1110. doi: 10.1001/jamaoto.2016.2168.
6
Prediction model to estimate overall survival benefit of postoperative radiotherapy for resected major salivary gland cancers.用于预测术后放疗对切除的主要涎腺癌总体生存获益的预测模型。
Oral Oncol. 2022 Sep;132:105955. doi: 10.1016/j.oraloncology.2022.105955. Epub 2022 Jun 22.
7
Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.计划性术后放疗前预测口腔鳞状细胞癌早期复发的因素及挽救性强化放疗后的结局。
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):363-373. doi: 10.1016/j.ijrobp.2018.09.013. Epub 2018 Sep 21.
8
Timing of postoperative radiation therapy for major salivary gland cancers.头颈部外照射治疗涎腺恶性肿瘤的时机选择。
Head Neck. 2024 Nov;46(11):2861-2869. doi: 10.1002/hed.27845. Epub 2024 Jun 12.
9
The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume.ⅢA期(N2)非小细胞肺癌患者术后放疗的新结局:基于三维适形放疗技术和机构标准临床靶区体积
BMC Cancer. 2015 May 2;15:348. doi: 10.1186/s12885-015-1326-6.
10
Management and outcome of patients with malignant salivary gland tumors.恶性唾液腺肿瘤患者的管理与预后
J Oral Maxillofac Surg. 2005 Jul;63(7):917-28. doi: 10.1016/j.joms.2005.03.006.

本文引用的文献

1
Management of Salivary Gland Malignancy: ASCO Guideline.唾液腺癌的治疗管理:ASCO 指南。
J Clin Oncol. 2021 Jun 10;39(17):1909-1941. doi: 10.1200/JCO.21.00449. Epub 2021 Apr 26.
2
Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: Incidence and outcomes by site and histological type.头颈部小唾液腺肿瘤-纪念斯隆凯特琳经验:部位和组织学类型的发生率和结果。
Cancer. 2019 Oct 1;125(19):3354-3366. doi: 10.1002/cncr.32208. Epub 2019 Jun 7.
3
Quantitative survival impact of composite treatment delays in head and neck cancer.头颈部癌症综合治疗延迟的定量生存影响。
Cancer. 2018 Aug 1;124(15):3154-3162. doi: 10.1002/cncr.31533. Epub 2018 May 9.
4
Outcomes and Prognostic Factors of Resected Salivary Gland Malignancies: Examining a Single Institution's 12-year Experience.唾液腺恶性肿瘤切除术后的结局和预后因素:基于单一机构12年经验的研究
Anticancer Res. 2017 Sep;37(9):5019-5025. doi: 10.21873/anticanres.11916.
5
Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.术后放射治疗开始时间对手术治疗的头颈癌患者生存的影响。
Cancer. 2017 Dec 15;123(24):4841-4850. doi: 10.1002/cncr.30939. Epub 2017 Aug 25.
6
Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapy.术后放疗后大唾液腺癌的结局与预后因素
Oral Oncol. 2016 Mar;54:75-80. doi: 10.1016/j.oraloncology.2015.11.023. Epub 2015 Dec 23.
7
Demographic trends and disease-specific survival in salivary acinic cell carcinoma: an analysis of 1129 cases.人口趋势和唾液腺腺样囊性癌的疾病特异性生存:1129 例分析。
Laryngoscope. 2014 Jan;124(1):172-8. doi: 10.1002/lary.24231. Epub 2013 Jul 12.
8
Major and minor salivary gland tumors.涎腺肿瘤。
Crit Rev Oncol Hematol. 2010 May;74(2):134-48. doi: 10.1016/j.critrevonc.2009.10.004. Epub 2009 Nov 24.
9
Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review.延迟开始治疗是否会影响放射治疗的结果?一项系统评价。
J Clin Oncol. 2003 Feb 1;21(3):555-63. doi: 10.1200/JCO.2003.04.171.
10
Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands.涎腺腺样囊性癌的快中子治疗结果。
Anticancer Res. 2000 Sep-Oct;20(5C):3743-9.